December 27, 2024 06:56 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
I have lost a mentor and guide: Rahul Gandhi writes on Manmohan Singh's demise | Manmohan Singh left strong imprint on our economic policy over years: PM Modi | A rare leader who spoke softly but achieved monumental strides: Gautam Adani mourns Manmohan Singh's death | Instagram influencer and freelance RJ Simran Singh dies by suicide in Gurugram | Anna University sexual assault case: Accused is a DMK worker, claims BJP's Annamalai | Celebrities too responsible for crowd control: Telangana CM Revanth Reddy to Telugu filmdom amid Pushpa 2 stampede row | Boat capsizes off Calangute Beach in Goa; 1 killed, 20 rescued | Canada announces change to immigration system, likely to impact Indians seeking permanent residence | Azerbaijan Airlines tragedy: 32 passengers rescued, flight attempted several emergency landing before crashing | Man sets himself on fire near Parliament building; locals, police rush him to hospital
Vaccine diplomacy: Advantage India as Sri Lanka replaces Chinese vaccine with India-made AstraZenca shots over safety concerns

Vaccine diplomacy: Advantage India as Sri Lanka replaces Chinese vaccine with India-made AstraZenca shots over safety concerns

Feb 27, 2021, at 04:57 am

Colombo/New Delhi/IBNS: In what is being viewed as a big win for India in vaccine diplomacy, Sri Lanka has put on hold Chinese Sinopharm's COVID-19 vaccine and would use India-manufactured Oxford AstraZeneca vaccine to vaccinate 14 million people, media reports said.